1. Home
  2. TRUP vs HROW Comparison

TRUP vs HROW Comparison

Compare TRUP & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trupanion Inc.

TRUP

Trupanion Inc.

HOLD

Current Price

$26.74

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo Harrow Inc.

HROW

Harrow Inc.

HOLD

Current Price

$46.41

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRUP
HROW
Founded
2000
1998
Country
United States
United States
Employees
N/A
373
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.4B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
TRUP
HROW
Price
$26.74
$46.41
Analyst Decision
Buy
Strong Buy
Analyst Count
5
8
Target Price
$45.80
$69.86
AVG Volume (30 Days)
355.5K
728.1K
Earning Date
04-30-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
295.65
N/A
EPS
0.11
N/A
Revenue
$1,439,305,000.00
N/A
Revenue This Year
$11.79
$31.62
Revenue Next Year
$8.83
$50.77
P/E Ratio
$239.91
N/A
Revenue Growth
11.95
N/A
52 Week Low
$21.16
$28.54
52 Week High
$57.00
$54.98

Technical Indicators

Market Signals
Indicator
TRUP
HROW
Relative Strength Index (RSI) 59.51 65.60
Support Level $24.47 $44.30
Resistance Level $27.35 $54.73
Average True Range (ATR) 1.03 2.28
MACD -0.01 -0.03
Stochastic Oscillator 73.17 83.74

Price Performance

Historical Comparison
TRUP
HROW

About TRUP Trupanion Inc.

Trupanion Inc is a specialty insurance products provider in the United States. Its core business is the sale of insurance products tailor-made for pets, especially cats and dogs. It operates in two business segments: The subscription business segment generates revenue majorly from subscription fees related to the company's direct-to-consumer products and Other business segment is comprised of revenue from other product offerings that generally have a business-to-business relationship and a different margin profile than subscription business segment, including revenue from writing policies on behalf of third parties and revenue from other products and software solutions. Geographically, the company operates in United States, which derives maximum revenue; and Canada and Others.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.

Share on Social Networks: